InvestorsHub Logo
icon url

DonDonDonDon

07/07/22 3:46 PM

#36644 RE: dloggold #36643

all im saying is in hindsight the company guilded the lily with the live air results.
but they did not fool the market…
and here we are with a paultry 150 mm market cap, and on the cusp of the best therapeutic in the market?
something is not jiving…..


Professional traders have refused to invest in biotech for quite some time. It didn't matter if the company was great and company's product was great. All biotech went down. Merit was 100% irrelevant. Just look at the XBI. It went from $178 down to a 5 year low of $61. Fortunately, biotech almost certainly has hit rock bottom. The biotech sector's rebound will be wind beneath HGEN's wings over the next couple of years.